Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses.

Aluminum hydroxide salts (alum) have been added to inactivated vaccines as safe and effective adjuvants to increase the effectiveness of vaccination. However, the exact cell types and immunological factors that initiate mucosal immune responses to alum adjuvants are unclear. In this study, the mecha...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Eita Sasaki, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, Isao Hamaguchi
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2021
Sujets:
Accès en ligne:https://doaj.org/article/15c234d22ce84c1fafd85299b4e18f64
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires